---
figid: PMC3801100__nihms-517201-f0001
figtitle: RSK isoforms control motility and other aspects of tumor cell invasion and
  metastasis
organisms:
- Homo sapiens
- Mus musculus
- Danio rerio
- Canis lupus familiaris
- unidentified
organisms_ner:
- Homo sapiens
- Canis lupus familiaris
- Mus musculus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC3801100
filename: nihms-517201-f0001.jpg
figlink: /pmc/articles/PMC3801100/figure/F1/
number: F1
caption: RSK isoforms control motility and other aspects of tumor cell invasion and
  metastasis. In response to hypoxia or hyperactivation of the RAF/ERK pathway through
  oncogenes, RSKs modulate motility and invasion through effects on transcription
  (1), integrin activity (2), and the remodeling of the actin cytoskeleton (3). (1)
  RSK1 and RSK2 drive Ras-ERK activated cell motility by inducing a transcriptional
  program leading to EMT. (2) RSK2 controls Ras mediated inactivation of integrins
  by phosphorylating Filamin A (FLNa), an adapter protein that binds integrin cytoplasmic
  tails, suppresses integrin activation and cell adhesion. (3) RSKs modulate cellular
  adhesions and the remodeling of the actin cytoskeleton either directly through phosphorylation
  of actin binding proteins (VASP or Hsp27) or indirectly through interference with
  RhoGTPase signaling (FAK or p27Kip).
papertitle: RSK isoforms in cancer cell invasion and metastasis.
reftext: Florian J. Sulzmaier, et al. Cancer Res. ;73(20):6099-6105.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9400691
figid_alias: PMC3801100__F1
figtype: Figure
redirect_from: /figures/PMC3801100__F1
ndex: 251a6c2a-dea5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3801100__nihms-517201-f0001.html
  '@type': Dataset
  description: RSK isoforms control motility and other aspects of tumor cell invasion
    and metastasis. In response to hypoxia or hyperactivation of the RAF/ERK pathway
    through oncogenes, RSKs modulate motility and invasion through effects on transcription
    (1), integrin activity (2), and the remodeling of the actin cytoskeleton (3).
    (1) RSK1 and RSK2 drive Ras-ERK activated cell motility by inducing a transcriptional
    program leading to EMT. (2) RSK2 controls Ras mediated inactivation of integrins
    by phosphorylating Filamin A (FLNa), an adapter protein that binds integrin cytoplasmic
    tails, suppresses integrin activation and cell adhesion. (3) RSKs modulate cellular
    adhesions and the remodeling of the actin cytoskeleton either directly through
    phosphorylation of actin binding proteins (VASP or Hsp27) or indirectly through
    interference with RhoGTPase signaling (FAK or p27Kip).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - EPHB2
  - MAPK1
  - MAPK3
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - JUN
  - JUNB
  - JUND
  - ITK
  - SLC22A3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - PTK2
  - CSE1L
  - CTNND1
  - BCAR1
  - TMX2-CTNND1
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - HSPB1
  - HSPB2
  - PEA15
  - VASP
  - Ephb2
  - Mapk1
  - Rps6ka1
  - Rps6ka3
  - Creb1
  - Jun
  - Itk
  - Slc22a3
  - Ptk2
  - Bcar1
  - Cse1l
  - Rho
  - Rhod
  - Ea2
  - Racgap1
  - Hspb2
  - Pea15a
  - Vasp
  - jun
  - ptk2ab
  - cse1l
  - sox32
  - rho
  - rnd2
  - hspb1
  - pea15
  - vaspb
  - vaspa
  - Mmp1
  - Erk7
  - rl
  - S6kII
  - CrebB
  - CrebA
  - Jra
  - scb
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Fak
  - rhea
  - cas
  - caz
  - Cse1
  - cass
  - cash
  - Bx
  - Rho1
  - Lcp65Ab1
  - cher
  - Hsp27
  - ena
---
